U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.
Feds to review parole status of immigrants released into the country“I got that close to getting them… But I just couldn’t”: Brothers lose home, 6 dogs in devastating fire
This photo provided by Vertex Pharmaceuticals in January 2025 shows a tablet of the JOURNAVX medication. “It’s not a slam dunk on effectiveness,” said Michael Schuh of the Mayo Clinic, a pharmacist and pain medicine expert who was not involved in the research. “But it is a slam dunk in that it’s a very different pathway and mechanism of action. So, I think that shows a lot promise.”
"In trying to develop medicines that don’t have the addictive risks of opioid medicines, a key factor is working to block pain signaling before it gets to the brain,” Vertex’s Dr. David Altshuler,“The new medication has side effect profiles that are inherently, not only different, but don’t involve the risk of substance abuse and other key side effects associated with opioids,” said Dr. Charles Argoff of the Albany Medical Center, who consulted for Vertex on the drug's development.
But the Boston drugmaker's share price plummeted in December when Vertex reported disappointing mid-stage results in a study of patients with chronic nerve pain affecting the lower back and legs. The drug didn't perform significantly better than placebo, the research found.
Health Charles Argoff David Altshuler Business Brian Abrahams
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Recalls Broccoli Florets Due to Listeria ContaminationA single production lot of washed and ready-to-eat 12 ounce bags of broccoli florets from Walmart is being recalled due to potential Listeria monocytogenes contamination.
Read more »
Eli Lilly Joins Lawsuit Against FDA Over Compounding PharmaciesEli Lilly has intervened in a legal battle between compounding pharmacies and the U.S. Food and Drug Administration (FDA) regarding the availability of Lilly's weight-loss and diabetes drugs. The company argues that the FDA's determination that these drugs are no longer in short supply could threaten its interests.
Read more »
FDA Issues Highest Risk Warning on Recalled Delta Fresh CucumbersThe FDA has issued a Class I recall for whole cucumbers produced by Delta Fresh of Arizona due to potential salmonella contamination, posing a serious risk to vulnerable individuals.
Read more »
FDA Proposes New Rules for Pulse Oximeters to Improve Accuracy for Patients of ColorThe FDA is proposing new rules that would require companies making pulse oximeters to conduct larger studies with more diverse patient populations. This comes after studies suggested that darker skin pigmentation can sometimes lead to inaccurate readings from these devices, which are crucial for monitoring oxygen levels in patients.
Read more »
FDA Proposes New Rules to Ensure Accuracy of Pulse Oximeters for All Skin TonesThe FDA is taking steps to address concerns about racial bias in medical technology by proposing new rules that would require manufacturers of pulse oximeters to demonstrate their products' accuracy for patients of all skin tones.
Read more »
FDA to Require More Data on Pulse Oximeters for Accuracy in People of ColorThe U.S. Food and Drug Administration (FDA) is proposing new rules that would require manufacturers of pulse oximeters to collect more data to ensure their devices accurately measure oxygen levels in people with darker skin tones.
Read more »